The effect of morbid obesity on the outcome of COVID-19 in a child
https://doi.org/10.22627/2072-8107-2022-21-3-47-51
Abstract
Numerous works of domestic and foreign colleagues have proved that obesity is an independent risk factor for severe COVID-19 among patients of all age groups. Of particular interest is the study of the effect of overweight on the course of a new coronavirus infection in children and adolescents.
Objective. Demonstration of a clinical case of fatal outcome of COVID-19 in a patient with morbid obesity; analysis and generalization of current data on the effect of obesity on the course of a new coronavirus infection in pediatric patients.
The article presents a general understanding of the pathogenetic relationship between the two pathologies, as well as a case of a fatal outcome of a new coronavirus infection in a 9-year-old 4-month-old girl with morbid obesity (BMI — 39 kg/m2, SDS BMI +4.98σ). Emphasis is placed on the lack of parallelism between the results of the procalcitonin test and the development of the septic process.
Conclusion. Studies of domestic and foreign colleagues, as well as the clinical case we have cited, confirm that morbid obesity is a risk factor for the adverse course of COVID-19 in children.
About the Authors
V. V. SokolovskayaRussian Federation
A. A. Litvinova
Russian Federation
A. V. Krikova
Russian Federation
R. S. Kozlov
Russian Federation
References
1. Demidova T.Yu., Volkova E.I., Gritskevich E.Yu. Features of the course and consequences of COVID-19 in overweight and obese patients. Lessons from the current pandemic. Ozhireniye i Мetabolizm=Obesity and Мetabolism. 2020; 17(4):375—384. (In Russ.) doi: https://doi.org/10.14341/omet12663
2. Yumuk V, Tsigos C, Fried M, et al. European Guidelines for Obesity Management in Adults. Nerurkar P V., ed. Obes Facts. 2015; 8(6):402—424. doi: https://doi.org/10.1159/000442721
3. United Nations Children’s Fund UNICEF Geneva World Heal Organ; 2022 [Cited 2022 June, 4]. [Internet]. Available from: https://www.unicef.org/documents/preventionoverweight-and-obesity-children-and-adolescents
4. Swann OV, Holden KA, Turtle L, Pollock L, Fairfield CJ, Drake TM, et al. Clinical characteristics of children and young people admitted to hospital with COVID-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020; 370:m3249. https://doi.org/10.1136/bmj.m3249
5. Simonnet A., Chetboun M., Poissy J., Raverdy V., Noulette J., Duhamel A. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020; 28:1195—1199. https://doi.org/10.1002/oby.22831
6. Nogueira-de-Almeida CA, Del Ciampo LA, Ferraz IS, Del Ciampo IRL, Contini AA, Ued FDV. COVID-19 and obesity in childhood and adolescence: a clinical review. J Pediatr (Rio J). 2020 Sep-Oct; 96(5):546—558. https://doi.org/10.1016/j.jped.2020.07.001
7. Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, Jacobson K. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. Int J Infect Dis. 2021 Feb; 103:246—256. https://doi.org/10.1016/j.ijid.2020.11.163
8. Cheng WA, Turner L, Marentes Ruiz CJ, Tanaka ML, Congrave-Wilson Z, Lee Y, Jumarang J, Perez S, Peralta A, Pannaraj PS. Clinical manifestations of COVID-19 differ by age and obesity status. Influenza Other Respir Viruses. 2022 Mar; 16(2):255—264. https://doi.org/10.1111/irv.12918
Review
For citations:
Sokolovskaya V.V., Litvinova A.A., Krikova A.V., Kozlov R.S. The effect of morbid obesity on the outcome of COVID-19 in a child. CHILDREN INFECTIONS. 2022;21(3):47-51. (In Russ.) https://doi.org/10.22627/2072-8107-2022-21-3-47-51